Biotech Values

[mcbio]

For the purposes of this survey (to keep it simple) please assume that GILD and ABBV/ENTA between them have 100% of the market for all-oral treatment of GT1 patients; thus, the survey is asking for a fraction where GILD’s all-oral GT1 sales are in the numerator and the sum of GILD’s and ABBV/ENTA’s all-oral GT1 sales are in the denominator.

That's quite an assumption. ; )